GENSIA PROJECTS 1995 FIRST QUARTER ANDA FOR GEOMATRIX NIFEDIPINE
Executive Summary
GENSIA PROJECTS 1995 FIRST QUARTER ANDA FOR GEOMATRIX NIFEDIPINE, a formulation that the San Diego-based firm hopes will be bioequivalent to Pfizer's Procardia XL. Gensia reported July 6 that "the company has selected a formulation for manufacturing scale-up which it believes has the potential to be a product which can achieve an AB equivalent rating to Procardia XL."